Arman Eshaghi
@armaneshaghi.bsky.social
Neuroscientist | NIHR Advanced Fellow at University College London | Montreal Neurological Institute Affiliate Member
Our latest research is in Nature Communications led by Philipp Goebl. Enabling insights from routine care MRI acquisitions. Check out the full paper here 👉 www.nature.com/articles/s41...
#MultipleSclerosis #MRI #DeepLearning #AIinMedicine
#MultipleSclerosis #MRI #DeepLearning #AIinMedicine
Enabling new insights from old scans by repurposing clinical MRI archives for multiple sclerosis research - Nature Communications
Here, the authors develop an AI tool called MindGlide that can extract key information from brain images acquired as part of the routine care of multiple-sclerosis patients to help interpret treatment...
www.nature.com
April 7, 2025 at 9:47 AM
Our latest research is in Nature Communications led by Philipp Goebl. Enabling insights from routine care MRI acquisitions. Check out the full paper here 👉 www.nature.com/articles/s41...
#MultipleSclerosis #MRI #DeepLearning #AIinMedicine
#MultipleSclerosis #MRI #DeepLearning #AIinMedicine
Reposted by Arman Eshaghi
As a teenager, Dr @armaneshaghi.bsky.social became interested in computer programming.
Now, he is developing AI tools with the potential to revolutionise multiple sclerosis treatment.
www.ucl.ac.uk/brain-scienc...
#BrainAwarenessWeek #UCLBrainSciences @uclqsion.bsky.social
Now, he is developing AI tools with the potential to revolutionise multiple sclerosis treatment.
www.ucl.ac.uk/brain-scienc...
#BrainAwarenessWeek #UCLBrainSciences @uclqsion.bsky.social
March 13, 2025 at 3:43 PM
As a teenager, Dr @armaneshaghi.bsky.social became interested in computer programming.
Now, he is developing AI tools with the potential to revolutionise multiple sclerosis treatment.
www.ucl.ac.uk/brain-scienc...
#BrainAwarenessWeek #UCLBrainSciences @uclqsion.bsky.social
Now, he is developing AI tools with the potential to revolutionise multiple sclerosis treatment.
www.ucl.ac.uk/brain-scienc...
#BrainAwarenessWeek #UCLBrainSciences @uclqsion.bsky.social
Reposted by Arman Eshaghi
Clinical research in the UK is under threat, partly because it takes so long to get a study or trial approved. Here are some of my suggested solutions in this BMJ Opinion piece
@nihr.bsky.social @wellcometrust.bsky.social @ukri.org
www.bmj.com/content/388/...
@nihr.bsky.social @wellcometrust.bsky.social @ukri.org
www.bmj.com/content/388/...
March 13, 2025 at 1:19 PM
Clinical research in the UK is under threat, partly because it takes so long to get a study or trial approved. Here are some of my suggested solutions in this BMJ Opinion piece
@nihr.bsky.social @wellcometrust.bsky.social @ukri.org
www.bmj.com/content/388/...
@nihr.bsky.social @wellcometrust.bsky.social @ukri.org
www.bmj.com/content/388/...
Trust and the Palantir question via @bmj.com www.bmj.com/content/388/...
Trust and the Palantir question
In healthcare we trust—or do we? A breakdown in trust, like the schism in the transatlantic alliance, should make us think again about whether the current model requires reinvention. An anonymous scie...
www.bmj.com
March 13, 2025 at 2:19 PM
Trust and the Palantir question via @bmj.com www.bmj.com/content/388/...